It has been estimated that 70% of the medicines given to children have only been tested in adults. The same is true when it comes to biomarkers. So, the NIH has opened up a new funding program aimed at taking biomarkers that may be effective in adults and developing them further for children. The NIH is accepting proposals for biomarkers developed in adults for use in pediatric diagnosis, prognosis and estimation of disease progression, toxicity and response to therapies. Story